Research Topics
Genomes and Genes | Dougald M MonroeSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) geneJ Y Chang
Center for Thrombosis and Hemostasis, University of North Carolina, Chapel Hill, USA
Thromb Haemost 81:45-9. 1999..In addition, heparin does not enhance the inhibition of factor Xa by mouse TFPIbeta although it does accelerate factor Xa inhibition by TFPI...
The clotting system - a major player in wound healingDougald M Monroe
Division of Hematology Oncology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7035, USA
Haemophilia 18:11-6. 2012..The goal of such treatment would be to avoid a feedback cycle in which bleeding tends to lead to further bleeding. Once initiated, this cycle may be difficult to control...
A possible mechanism of action of activated factor VII independent of tissue factorD M Monroe
Department of Medicine, University of North Carolina, Chapel Hill 27599 7035, USA
Blood Coagul Fibrinolysis 9:S15-20. 1998..We speculate that this platelet-localized thrombin generation may, in part, account for the clinical efficacy of high-dose FVIIa...
The tissue factor-factor VIIa complex: procoagulant activity, regulation, and multitaskingD M Monroe
Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
J Thromb Haemost 5:1097-105. 2007..This article reviews current knowledge on the function and regulation of TF and its role in a range of biological processes, including hemostasis, thrombosis and inflammation...
Fathers of modern coagulationDougald M Monroe
UNC Medical School--Hematology/Oncology, 932 Mary Ellen Jones, CB#7035 Chapel Hill, North Carolina 27599-7035, USA
Thromb Haemost 98:3-5. 2007
Platelets and thrombin generationDougald M Monroe
Center for Thrombosis and Hemostasis, University of North Carolina, Chapel Hill 27599 7035, USA
Arterioscler Thromb Vasc Biol 22:1381-9. 2002..Individual differences in platelet thrombin generation might be accounted for by differences in platelet-binding proteins...
Coagulation factor interaction with plateletsDougald M Monroe
Center for Thrombosis and Hemostasis, University of North Carolina, Chapel Hill, NC, USA
Thromb Haemost 88:179. 2002
Further understanding of recombinant activated factor VII mode of actionDougald M Monroe
Division of Hematology Oncology, Department of Medicine, Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7035, USA
Semin Hematol 45:S7-S11. 2008..However, the platelet surface may be able to process only a limited amount of FXa, accounting for the observation that some models of non-hemophilic coagulopathy show a plateau in the effect of rFVIIa...
Modeling the action of factor VIIa in dilutional coagulopathyDougald M Monroe
Division of Hematology Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC 27599 7035, USA
Thromb Res 122:S7-S10. 2008..This may suggest a mechanism to account for the efficacy of factor VIIa in reducing blood loss in some settings of dilutional coagulopathy...
The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathiaD M Monroe
Center for Thrombosis and Hemostasis, UNC School of Medicine, Chapel Hill, North Carolina, USA
Semin Thromb Hemost 26:373-7. 2000..Finally, enhanced thrombin generation on platelets would mean that fewer platelets are required for hemostasis...
High dose factor VIIa improves clot structure and stability in a model of haemophilia BAlisa S Wolberg
Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, NC 27599 7525, USA
Br J Haematol 131:645-55. 2005....
The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administrationM Kjalke
Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, USA
Thromb Haemost 78:1202-8. 1997....
Wound healing in hemophilia B mice and low tissue factor miceDougald M Monroe
School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA
Thromb Res 125:S74-7. 2010..The current data suggests that ongoing coagulation function needs to be maintained to support a normal wound healing process...
The coagulation cascade in cirrhosisDougald M Monroe
Carolina Cardiovascular Biology Center, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
Clin Liver Dis 13:1-9. 2009..This allows the coagulation system to be more easily tipped into a state favoring either hemorrhage or thrombosis...
Platelet heterogeneity: variation in coagulation complexes on platelet subpopulationsChristine L Kempton
University of North Carolina, Chapel Hill, NC 27599-7035, USA
Arterioscler Thromb Vasc Biol 25:861-6. 2005..Convulxin-induced increases in thrombin generation are regulated by the proportion of platelets with increased coagulation factor binding...
Safety profile of recombinant factor VIIaHarold R Roberts
Division of Hematology, Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, USA
Semin Hematol 41:101-8. 2004..Finally, those situations in which rFVIIa therapy may not be safe, such as disseminated intravascular coagulation (DIC) and sepsis, will also be discussed...
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic riskAlisa S Wolberg
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, USA
Blood 101:3008-13. 2003..We hypothesize that this alteration in fibrin clot structure is an important determinant of the risk of thrombosis...
Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophiliaAnna G McDonald
Duke University, Durham, NC, USA
Blood 111:2046-8. 2008..Thus, perivascular TF expression is down-regulated during wound healing. This may prevent thrombosis of neovessels during angiogenesis but renders hemophiliacs vulnerable to hemorrhage during healing...
The use of recombinant factor VIIa in the treatment of bleeding disordersHarold R Roberts
Division of Hematology Oncology, Department of Medicine and The Carolina Cardiovascular Biology Center, 932 Mary Ellen Jones Bldg, Chapel Hill, NC 27599 7035, USA
Blood 104:3858-64. 2004..Several questions pertaining to the use of factor VIIa require further investigation, including the mechanism of action; the optimal dose; definitive indications; ultimate safety; and laboratory tests for monitoring therapy...
Activation of protease-activated receptors 3 and 4 accelerates tissue factor-induced thrombin generation on the surface of vascular smooth muscle cellsParam Vidwan
Division of Cardiology, University of North Carolina, Chapel Hill 27599 7075, USA
Arterioscler Thromb Vasc Biol 30:2587-96. 2010..To determine factors regulating human aortic smooth muscle cells (HASMC) supported tissue factor-induced thrombin generation...
Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulationM Kjalke
Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, USA
Thromb Haemost 80:578-84. 1998..Thrombin then activates platelets, which serve as the physiologically important surface for large-scale thrombin generation...
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitorJen Yea Chang
Department of Medicine, University of North Carolina at Chapel Hill, NC 27599, USA
Thromb Res 130:e151-7. 2012..These results suggest that BAX499 may be a useful addition to the armamentarium of bypassing agents to control bleeding in hemophilic patients with inhibitors...
A cell-based model of thrombin generationHarold R Roberts
School of Medicine, Division of Hematology Oncology, Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, North Carolina 27599 7035, USA
Semin Thromb Hemost 32:32-8. 2006..We have also shown that activated protein C does not inactivate Va on the platelet surface but rather on endothelial cell surfaces...
Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfacesJulie A Oliver
Duke University and the Durham VA Medical Hospital, Durham, NC, USA
Blood 100:539-46. 2002..From the studies reported here, we conclude that in vivo, despite the important role of the protein C system in regulating thrombosis, activated protein C does not serve as a primary regulator of platelet-dependent thrombin generation...
The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulationM Kjalke
University of North Carolina at Chapel Hill, USA
Blood Coagul Fibrinolysis 9:S21-5. 1998....
Current concepts of hemostasis: implications for therapyHarold R Roberts
Division of Hematology Oncology, Carolina Cardiovascular Biology Center, University of North Carolina School of Medicine, Chapel Hill 27599 7035, USA
Anesthesiology 100:722-30. 2004..Finally, recombinant factor VIIa has been used off-label as a hemostatic agent in some surgical situations associated with excessive bleeding that is not responsive to conventional therapy...
A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet functionAlisa S Wolberg
Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
J Trauma 56:1221-8. 2004..However, at temperatures below 33 degrees C, both reduced platelet function and enzyme activity likely contribute to the coagulopathy...
Cutaneous wound healing is impaired in hemophilia BMaureane Hoffman
Laboratory Service 113, Durham Veterans Affairs Medical Center, 508 Fulton St, Durham, NC 27705, USA
Blood 108:3053-60. 2006..Our findings have significant implications for treatment of patients with hemophilia, and also highlight the importance of rapidly establishing hemostasis following trauma or surgery...
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhageGeoffrey A Allen
Center for Thrombosis and Hemostasis and Pediatric Hematology Oncology, University of North Carolina School of Medicine, Chapel Hill 27599 7220, USA
Can J Anaesth 49:S7-14. 2002..We have attempted to reconcile the various proposed mechanisms of action of rFVIIa with its apparent efficacy in such diverse clinical settings...
Wound healing in haemophilia--breaking the vicious cycleM Hoffman
Pathology and Laboratory Medicine Service, Durham VA Medical Center, Durham, NC 27705, USA
Haemophilia 16:13-8. 2010..Thus, normalizing haemostasis, until the process of angiogenesis has resolved, may be required to prevent re-bleeding and additional tissue damage...
Tissue factor around dermal vessels has bound factor VII in the absence of injuryM Hoffman
Duke University Medical Center, Durham, NC, USA
J Thromb Haemost 5:1403-8. 2007..Idling' or ongoing low-level activity of the tissue factor (TF) pathway is a postulated mechanism by which the coagulation process can become active without a lag period at sites of injury...
Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis?M Hoffman
Duke University Medical Center, Durham, NC, USA
Immunol Res 22:191-7. 2000..quot;Antiphospholipid" antibodies against the phospholipid-binding protein beta-2-glycoprotein-1 enhance thrombin generation in this model system, primarily by enhancing procoagulant reactions on tissue factor-bearing cells...
Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VIIM Hoffman
Department of Pathology, Durham Veterans Affairs Medical Center, NC 27705, USA
Blood Coagul Fibrinolysis 9:S61-5. 1998..Activation of FIX and FX on platelet surfaces in thrombocytopenia would result in more thrombin generation per platelet, possibly leading to formation of a stable fibrin network even in the absence of an optimal initial platelet plug...
A cell-based model of hemostasisM Hoffman
Pathology and Laboratory Medicine Service, Durham VA, Medical Center, NC 27705, USA
Thromb Haemost 85:958-65. 2001..This cell based model explains some aspects of hemostasis that a protein-centric model does not...
Impact of procoagulant concentration on rate, peak and total thrombin generation in a model systemG A Allen
Department of Pediatrics Department of Pathology and Laboratory Medicine Department of Medicine Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, NC, USA
J Thromb Haemost 2:402-13. 2004....
Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI)J Y Chang
Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, 27599 7035, USA
Thromb Haemost 79:306-9. 1998..Cloning and expression of the mouse TFPI gene will offer useful information and material for coagulation studies performed in a mouse model system...
Role of the gamma-carboxyglutamic acid domain of activated factor X in the presence of calcium during inhibition by antithrombin-heparinH C Whinna
Department of Pathology and Laboratory Medicine, Carolina Cardiovascular Biology Center, The University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
J Thromb Haemost 2:1127-34. 2004..Recently, Rezaie showed that calcium further enhanced the heparin-catalyzed AT inhibition of FXa by promoting 'ternary complex' formation, and these results showed a role for the gamma-carboxyl-glutamate (Gla)-domain of FXa...
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia BJ Y Chang
Center for Thrombosis and Hemostasis, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7035, USA
J Clin Invest 100:886-92. 1997....
Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated plateletsD A Gabriel
Division of Hematology Oncology, The Bone Marrow Transplant Program and The University of North Carolina School of Medicine, Carolina Center for Cardiovascular Biology, Chapel Hill, NC 27599, USA
J Thromb Haemost 2:1816-22. 2004....
What does it take to make the perfect clot?Dougald M Monroe
Durham Veterans Affairs Medical Center, Department of Pathology, Duke University Medical Center, Durham, NC, USA
Arterioscler Thromb Vasc Biol 26:41-8. 2006..Our understanding of how specific cellular features control the processes of hemostasis and thrombosis is developing rapidly. This review discusses some aspects of the cellular control of coagulation...
Thrombin generation in vascular tissueA Pathak
Division of Cardiology, Hematology and Cardiothoracic Surgery and Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, NC 27599 7075, USA
J Thromb Haemost 4:60-7. 2006..Classically, it is thought that the vast majority of thrombin is generated on the surface of platelets, however, thrombotic events occur in patients despite treatment with potent antiplatelet agents...
Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factorS Chaing
Department of Medicine, University of North Carolina at Chapel Hill
Blood 83:3524-35. 1994..Our results suggest that the first EGF-like domain is required for binding to tissue factor and that the F.VII zymogen lacks activity and requires activation for expression of biologic activity...
Low intensity laser therapy speeds wound healing in hemophilia by enhancing platelet procoagulant activityMaureane Hoffman
Department of Pathology, Duke University and Durham Veterans Affairs Medical Centers, Durham, North Carolina 27705, USA
Wound Repair Regen 20:770-7. 2012..These data suggest that trials of LILT as an adjunct to the usual hemostatic therapies in hemophilia are warranted...
Functional consequences of an arginine180 to glutamine mutation in factor IX HiloD M Monroe
Department of Medicine, University of North Carolina, Chapel Hill
Blood 73:1540-4. 1989..Further, our data suggest that the mutation results in a molecule that interacts with components of the extrinsic pathway to give a prolonged ox brain prothrombin time...
Mechanism of action of high-dose factor VIIa: points of agreement and disagreementDougald M Monroe
Arterioscler Thromb Vasc Biol 23:8-9; discussion 10. 2003
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasisMaureane Hoffman
Dis Mon 49:14-21. 2003..Our data suggest that in a cellular system high-dose FVIIa acts primarily by enhancing the rate of thrombin generation on platelet surfaces and not by overcoming inhibition by zymogen FVII of TF-dependent activation of FX...
The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patientsZhi Hong Meng
Department of Pathology, Duke University Medical Center, Durham, NC 27705, USA
J Trauma 55:886-91. 2003..CONCLUSION: FVIIa should be effective in enhancing hemostasis in hypothermic patients. However, because the activity of FVIIa is so dramatically affected by pH, its efficacy may be reduced in acidotic patients...
Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophiliaGeoffrey A Allen
Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Br J Haematol 134:314-9. 2006..Furthermore, these results suggest that increasing plasma prothrombin concentration prior to rFVIIa administration may offer advantages over the use of rFVIIa alone in the treatment of haemophilic bleeding...
Rethinking the coagulation cascadeMaureane M Hoffman
Department of Pathology, Durham Veterans Affairs Medical Center, Durham, NC 27705, USA
Curr Hematol Rep 4:391-6. 2005..It also highlights how host factors that are not part of the coagulation process per se can influence the effectiveness of coagulation...
Coagulation 2006: a modern view of hemostasisMaureane Hoffman
Pathology and Laboratory Medicine Service 113, Durham Veterans Affairs Medical Center, 508 Fulton Street, Durham, NC 27705, USA
Hematol Oncol Clin North Am 21:1-11. 2007..Generation of the right amount of thrombin during the coagulation process not only may be essential for effective hemostasis but also may set the stage for effective wound healing...
More information on patients with factor XI deficiencyHarold R Roberts
Anesthesiology 101:1253-4. 2004
